
Opinion|Videos|June 18, 2024
Navigating Therapy Approval for Early Breast Cancer: An Operational Perspective
Medical experts discuss their perspectives on therapy approval and the significance of formulary inclusion, emphasizing the need to carefully consider both toxicities and benefits, which may ultimately lead to the operationalization of a drug in clinical practice.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
How will the potential approval of ribociclib for early breast cancer change your treatment paradigms?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First-in-Class Centanafadine for ADHD in Adults and Pediatric Patients
2
Why COVID-19 Prevention Still Matters During 2026's Summer Surge
3
Multi-Channel Engagement and Pharmacist-Prescriber Collaboration in Tardive Dyskinesia Care
4
Pharmacists Are Critical to SGLT2, GLP-1 Use in CKD
5








































































































